COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Press Releases

  • Home/In The News/Press/KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.

KRS Global Biotechnology, Inc. Announces the Compounded Service of Nitroglycerin.

FDA registered and inspected 503B Human Outsourcing Facility, KRS Global Biotechnology, Inc. who specializes in the preparation of drugs no longer commercially available or in short supply, announces today that they are providing the service of compounded nitroglycerin.

BOCA RATON, FL., 7 July 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it is providing the compounding service of nitroglycerin. Aside from authorized international shipments of the drug into the United States, the company is the only FDA registered and inspected Outsourcing Facility providing the service of compounded nitroglycerin.

First reported in the New York Times in March 2014, this medication is important in the emergency setting to assist with managing chest pain and severe hypertensive situations. However, supply shortages and recalls from major drug manufactures have caused concern. The Primary reason for concern is there is no real substitute for the IV form of nitroglycerin.

http://www.nytimes.com/2014/03/26/business/nitroglycerin-a-staple-of-emergency-rooms-is-in-short-supply.html

According to the American Society of Health System Pharmacists, over 300 drugs are in short supply. Thirty percent are due to manufacturing delays. Although the FDA has taken action on this to encourage drug manufacturers to produce more, they cannot force them to increase production on a particular drug.

http://formularyjournal.modernmedicine.com/formulary-journal/news/iv-nitroglycerin-shortage-concerning-manageable?page=full

A representative from the company states that, ‘there seems to be no resolution to drug shortages soon. Therefore, hospitals should consider planning ahead and using other alternative sources, such as Outsourcing Facilities, for their drug shortages needs.’

About KRS Global Biotechnology, Inc.

KRS Global Biotechnology, Inc. has been serving the Healthcare Community since 2001. KRS Global is a FDA registered and inspected Human Outsourcing Facility that specializes in providing medications that are not commercially available or in short supply from distributors & manufacturers.

For more information, contact:

John Swartz, Vice President, Business Development
Phone: 888-242-7996
E-mail: johnswartz@gbtbio.com

Website: www.gbtbio.com